Skip Over Navigation Links

About NCATS

Cures Acceleration Network Review Board

Authorized to reduce significant barriers to successful translation and accelerate the development of high-need cures, the Cures Acceleration Network (CAN) provides NCATS with flexibility in how it funds projects. Implementation of this authority is guided by the CAN Review Board, which according to its charter, advises and provides recommendations to the NCATS director on the policies, programs and procedures for carrying out the duties of the Office of the Director and on identifying significant barriers to successful translation of basic science into clinical application.

Members

The Board is comprised of members who are appointed by the Secretary of the U.S. Department of Health and Human Services. Members serve four-year terms. Ex-officio members from NIH, the Office of the Assistant Secretary of Defense for Health Affairs, the Office of the Under Secretary for Health for the Department of Veterans Affairs, the National Science Foundation, and the U.S. Food and Drug Administration also are appointed and serve three-year terms.

Meeting Information

The CAN Review Board meets four times each year. View the schedule below for upcoming meetings; past meeting minutes, agendas and videocasts also are available.

2014

NCATS Advisory Council and CAN Review Board Meeting

September 19, 2014
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 6
Bethesda, Md. 20852

This joint meeting of the NCATS Advisory Council and Cures Acceleration Network (CAN) Review Board will feature presentations by NCATS leadership, the CAN Review Board and invited guests. Presentations will include a Director’s Report, trends in NINDS funding of basic and applied neuroscience, as well as CTSA and Tissue Chip for Drug Screening program updates. Council subcommittees also will report on 1) patient engagement; 2) partnerships with pharmaceutical and biotechnology companies, and venture capital firms; and 3) medical technologies. In addition, NCATS staff will present CAN and Council Concept Clearances of proposed initiatives for consideration and approval by Council.

Federal Register Notice

December 12

2015

January 15-16

May 21-22

September 24-25

December 11

IOM Workshop on CAN

As requested by Congress, NCATS contracted with the Institute of Medicine (IOM) to host a two-day workshop to discuss the authorities provided to NCATS by the recently authorized Cures Acceleration Network (CAN). “Maximizing the Goals of the Cures Acceleration Network to Accelerate the Development of New Drugs and Diagnostics: A Workshop” was held on June 4-5, 2012.

A workshop summary is available. For more information, visit the IOM website.